| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |